Ribavirin with or without alpha interferon versus no intervention, placebo or alpha interferon for chronic hepatitis C

Hepatitis C is a major cause of liver-related morbidity and mortality. Ribavirin plus interferon combination therapy is presently considered the optimal treatment of interferon naive patients with chronic hepatitis C, but its role in relapsers and non-responders to previous interferon therapy is not...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cochrane database of systematic reviews 2002 (1), p.CD002234-CD002234
Hauptverfasser:	Kjaergard, L L, Krogsgaard, K, Gluud, C
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral Agents - therapeutic use Drug Therapy, Combination Hepatitis C, Chronic - drug therapy Humans Interferon-alpha - therapeutic use Randomized Controlled Trials as Topic Ribavirin - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!